- Home
- CELZ vs TLPH Comparison
CELZ vs TLPH Comparison
Compare CELZ & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- TLPH
- Stock Information
- Founded
- CELZ 1998
- TLPH 2005
- Country
- CELZ United States
- TLPH United States
- Employees
- CELZ N/A
- TLPH N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- TLPH Health Care
- Exchange
- CELZ Nasdaq
- TLPH Nasdaq
- Market Cap
- CELZ 10.4M
- TLPH 11.1M
- IPO Year
- CELZ N/A
- TLPH 2011
- Fundamental
- Price
- CELZ $5.59
- TLPH $1.30
- Analyst Decision
- CELZ
- TLPH Strong Buy
- Analyst Count
- CELZ 0
- TLPH 1
- Target Price
- CELZ N/A
- TLPH $6.00
- AVG Volume (30 Days)
- CELZ 88.8K
- TLPH 491.4K
- Earning Date
- CELZ 11-12-2025
- TLPH 11-12-2025
- Dividend Yield
- CELZ N/A
- TLPH N/A
- EPS Growth
- CELZ N/A
- TLPH N/A
- EPS
- CELZ N/A
- TLPH N/A
- Revenue
- CELZ $6,000.00
- TLPH $27,000.00
- Revenue This Year
- CELZ N/A
- TLPH N/A
- Revenue Next Year
- CELZ N/A
- TLPH $14,533.26
- P/E Ratio
- CELZ N/A
- TLPH N/A
- Revenue Growth
- CELZ N/A
- TLPH N/A
- 52 Week Low
- CELZ $1.69
- TLPH $0.38
- 52 Week High
- CELZ $6.90
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- CELZ 82.55
- TLPH 67.99
- Support Level
- CELZ $3.35
- TLPH $1.12
- Resistance Level
- CELZ $4.23
- TLPH $1.19
- Average True Range (ATR)
- CELZ 0.40
- TLPH 0.11
- MACD
- CELZ 0.20
- TLPH -0.01
- Stochastic Oscillator
- CELZ 77.63
- TLPH 74.18
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.